International Consensus in Aiming to Define "Refractory ITP"
Blood Adv
.
2025 Jan 9:bloodadvances.2024015219.
doi: 10.1182/bloodadvances.2024015219.
Online ahead of print.
Authors
Candelaria O'Farrell
1
,
Amanda B Grimes
1
,
Taizo A Nakano
2
,
Robert J Klaassen
3
,
Michele P Lambert
4
,
Cindy E Neunert
5
,
Jennifer A Rothman
6
,
Kristin A Shimano
7
,
Rachael F Grace
8
Affiliations
1
Baylor College of Medicine, Houston, Texas, United States.
2
Children's Hospital Colorado, Denver, Colorado, United States.
3
Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada.
4
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States.
5
Columbia University Irving Medical Center, New York, New York, United States.
6
Duke University Medical Center, Durham, North Carolina, United States.
7
University of California San Francisco, San Francisco, California, United States.
8
Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, United States.
PMID:
39787601
DOI:
10.1182/bloodadvances.2024015219
No abstract available